Scope and Limitations of Pd2(dba)3/P(i-BuNCH2CH2)3N-Catalyzed Buchwald−Hartwig Amination Reactions of Aryl Chlorides
摘要:
Proazaphosphatrane ligands in combination with Pd-2(dba)(3) generate highly active catalysts for Buchwald-Hartwig amination of aryl chlorides. In particular, commercially available P(i-BuNCH2-CH2)(3)N is a highly general and efficient ligand, allowing the coupling of an electronically diverse set of aryl chlorides, including chloropyridines, with a wide variety of amines using 1 mol % of Pd at 100 degreesC. Either a 1:1 or 2:1 ratio of ligand to Pd was found to be effective. This catalyst system performs exceptionally well for sterically hindered substrates, even with only 0.25 mol % of Pd. It is shown that NaOH can also be used as the base (instead of NaO-t-Bu) allowing functionalized substrates to participate in these reactions.
[EN] NOVEL TETRAHYDROPYRIDOPYRIMIDINES AND TETRAHYDROPYRIDOPYRIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION<br/>[FR] NOUVELLES TÉTRAHYDROPYRIDOPYRIMIDINES ET TÉTRAHYDROPYRIDOPYRIDINES POUR LE TRAITEMENT ET LA PRÉVENTION D'UNE INFECTION PAR LE VIRUS DE L'HÉPATITE B
申请人:HOFFMANN LA ROCHE
公开号:WO2016107832A1
公开(公告)日:2016-07-07
The invention provides novel compounds having the general formula (I): wherein R1, R2, R3, Q, U,W, Z, X and Y are as described herein, compositions including the compounds and methods of using the compounds. These compounds are HbsAg inhibitors and are useful as medicaments for the treatment or prophylaxis of HBV infection.
PIFA-Promoted, Solvent-Controlled Selective Functionalization of C(sp<sup>2</sup>)–H or C(sp<sup>3</sup>)–H: Nitration via C–N Bond Cleavage of CH<sub>3</sub>NO<sub>2</sub>, Cyanation, or Oxygenation in Water
作者:Chandrashekar Mudithanapelli、Lama Prema Dhorma、Mi-hyun Kim
DOI:10.1021/acs.orglett.9b00751
日期:2019.5.3
CH3NO2) mediated by [bis(trifluoroacetoxy)iodo]benzene (PIFA) is described. The NO2 transfer from CH3NO2 to the aromatic group of the substrate is possible with careful selection of the solvent, NaX, and oxidant. In addition, the solvent-controlled C(sp2)–H functionalization can shift to an α-C(sp3)–H functionalization (cyanation or oxygenation) of the α-C(sp3)–H of cyclic amines.
描述了由[双(三氟乙酰氧基)碘]苯(PIFA)介导的新型硝化作用(通过C(sp 3)–N破坏/ C(sp 2)–N与CH 3 NO 2形成)。的NO 2从CH转印3 NO 2到基板的芳族基团是可能的溶剂,的NaX,和氧化剂的仔细选择。此外,溶剂控制的C(SP 2)-H官能化可转移到一个α-C(SP 3)-H官能的α-C(SP的(氰化或氧合)3)-H的环胺。
Ligand- and Base-Free Copper(II)-Catalyzed C−N Bond Formation: Cross-Coupling Reactions of Organoboron Compounds with Aliphatic Amines and Anilines
作者:Tan D. Quach、Robert A. Batey
DOI:10.1021/ol035681s
日期:2003.11.1
[reaction: see text] A ligandless and base-free Cu-catalyzed protocol for the cross-coupling of arylboronic acids and potassium aryltrifluoroborate salts with primary and secondary aliphatic amines and anilines is described. The process utilizes catalytic copper(II) acetate monohydrate and 4 A molecular sieves in dichloromethane at slightly elevated temperatures under an atmosphere of oxygen. A broad
Metal-free late-stage C(sp<sup>2</sup>)–H functionalization of<i>N</i>-aryl amines with various sodium salts
作者:Chandrashekar Mudithanapelli、Mi-hyun Kim
DOI:10.1039/c9ob02217a
日期:——
Metal-free consecutive C(sp2)–X (X = Cl, Br, S, N) bond formations of N-aryl amines (cyclic, fused, carbamate, and aminium radicals) were achieved under mild conditions using [bis(trifluoroacetoxy)iodo]benzene (PIFA) and simple nonharmful sodium salts. This direct and selective C(sp2)–H functionalization showed excellent functional group compatibility, cost effectiveness, and late-stage applicability
不含金属的连续的C(SP 2)-X(X =氯,溴,S,N)的键形成ñ -芳基胺(环状,稠合,氨基甲酸酯,和铵基团)使用[双温和的条件下实现(三氟乙酰氧基)碘]苯(PIFA)和简单的无害钠盐。这种直接和选择性的C(sp 2)–H官能化显示出优异的官能团相容性,成本效益和生物活性天然产物合成的后期适用性。提出了两种机制来解释邻位或对位偏爱以及CH 3 NO 2的加速作用。
Novel Piperidine Derivative
申请人:Ishikawa Shiho
公开号:US20090137576A1
公开(公告)日:2009-05-28
Disclosed is a substance having an antagonistic effect on the binding of histamine to a histamine H3 receptor or an inhibitory effect on the activity which a histamine H3 receptor constantly exhibits. A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof; (I)
wherein R1 represents a phenyl group which may be substituted or the like and R2 represents a cyano group which may be substituted or the like, or R1 and R2 together form an aliphatic heterocylic ring which may be substituted; R3 represents a group represented by the formula (II-1) below;
and all of X1 to X4 represent a carbon atom or the like: (II-1) where R4 and R5 represent a lower alkyl group or the like; and m1 represents an integer of 2 to 4.